Seed · AI & Machine Learning · Vilnius, Lithuania · Founded 2018 · 28–30 employees
Biomatter is a synthetic biology company that uses AI to create enzymes that don't exist in nature through its Intelligent Architecture™ platform. The company achieved a breakthrough in 2019 by unveiling the first fully functional enzymes created with generative AI, published in Nature Machine Intelligence. They have partnerships with major companies like Thermo Fisher Scientific, BASF, and Neogen, and have successfully collaborated with Kirin to produce Human Milk Oligosaccharides for infant nutrition. In August 2024, they raised €6.5 million in seed funding to further develop their platform.